India's Jubilant Pharma may acquisition unnamed US firm
Jubilant Pharma, a unit of Indian pharmaceutical company Jubilant Life Sciences, is in negotiations to acquire an unnamed US speciality pharma business. Jubilant Life Sciences shares rose 0.59% to INR790 on the Bombay Stock Exchange.
Home

News

Agencies

Jubilant Life Sciences looks to buy specialty pharma biz in US

Jubilant Life Sciences looks to buy specialty pharma biz in US

New Delhi, Mar 21 (PTI) Jubilant Life Sciences today said its subsidiary Jubilant Pharma will negotiate a potential acquisition of a specialty business in the US."The Board of Directors of Jubilant Ph

New Delhi, Mar 21 (PTI) Jubilant Life Sciences today said its subsidiary Jubilant Pharma will negotiate a potential acquisition of a specialty business in the US.

“The Board of Directors of Jubilant Pharma Ltd, a material wholly-owned subsidiary of the company in Singapore, has approved to negotiate a potential acquisition of a specialty pharma business in the United States using only internal accruals,” Jubilant Life Sciences said in a BSE filing.

You may like to read

The potential acquisition will be subject to due diligence, satisfactory agreements, etc and final approval of Jubilant Life Sciences.

It further said: “The proposed acquisition is a niche, profitable speciality pharma business with a strategic fit and is expected to provide competitive edge for JPL’s existing business, if it materialises”.

Shares of Jubilant Life Sciences were trading 0.59 per cent up at Rs 790 apiece on BSE.

This is published unedited from the PTI feed.

For breaking news and live news updates, like us on Facebook or follow us on Twitter and Instagram. Read more on Latest News on India.com.